登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Clusterin】

Clusterin信息

英文名称:Clusterin
中文名称:丛生蛋白
靶点别称:Epididymis Secretory Sperm Binding Protein,CLI,Apolipoprotein J,ApoJbeta,Complement cytolysis inhibitor a chain,Testosterone-repressed prostate message 2,Complement cytolysis inhibitor b chain,ApoJalpha,AAG4,Complement cytolysis inhibitor,NA1/NA2,APOJ,CLU,Clusterin,Complement-Associated Protein SP-40,40,Complement Lysis Inhibitor,Sulfated Glycoprotein 2,Ku70-Binding Protein 1,TRPM-2,KUB1,Clusterin (Complement Lysis Inhibitor, SP-40,40, Sulfated Glycoprotein 2, Testosterone-Repressed Prostate Mes
上市药物数量:0
临床药物数量:1
最高研发阶段:临床二期

Clusterin产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
CLU-H5227
Human
Human Clusterin / CLUS Protein, His Tag
ACRO质量管理体系
 
评论(0)
 

Clusterin分子别名

CLU,Clusterin,AAG4,APOJ,CLI,KUB1,SGP-2,SP-40,TRPM2

Clusterin分子背景

Clusterin (CLU) is also known as dimeric acidic glycoprotein (DAG protein), testosterone repressed prostate message-2 (TRPM-2), sulfated glycoprotein-2 (SGP-2) and complement lysis inhibitor (CLI), is a secreted multifunctional glycoprotein protein which belongs to the clusterin family. Intracellular cleavages of the precursor of clusterin remove the signal peptide and generate comparably sized α and β chains which are secreted as an 80 kDa N­glycosylated disulfide­linked heterodimer. DAG protein is predominantly expressed in adult testis, ovary, adrenal gland, liver, heart, and brain and in many epithelial tissues during embryonic development. Clusterin involve in several basic biological events such as cell death, tumor progression, and neurodegenerative disorders. Upregulation of clusterin mRNA and protein levels detected in diverse disease states and in in vitro systems have led to suggestions that it functions in membrane lipid recycling, in apoptotic cell death, and as a stress-induced secreted chaperone protein, amongst others.

Clusterin临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Sotevtamab AB-sCLU mAB; 16B5; AB-16B5 临床二期 National Research Council Biotechnology Research Institute 实体瘤, 非小细胞肺癌, 转移癌 详情

消息提示

请输入您的联系方式,再点击提交!

确定